Abstract
The biotransformation of DMBA in uninduced and induced 10,000g organ supernatants derived from female Sprague-Dawley and Long-Evans rats, which are respectively sensitive and resistant to DMBA-induced carcinogenesis, was studied. Qualitative and quantitative differences in the metabolism of DMBA are summarized as a function of organ (liver, lung, kidney, and mammary) and strain and oxidative enzyme induction protocol utilized and are attributed to the differential induction of various cytochrome P-450s. The percent production of 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol (DMBA-3,4-DHD) and phenol metabolites in 10,000g organ supernatants from beta-napthoflavone induced animals correlated with organ susceptibility to DMBA-induced carcinogenesis in both SD and LE rat strains. A negative correlation was observed between 8,9-DHD production and reported sensitivity to specific organ tumorigenesis, but no other relationship was observed with other metabolites (7- and 12-hydroxymethyl, K-region DHD, and 10,11-DHDs). Similar DMBA metabolite hplc profiles were observed in the same organ S-10 fractions isolated from either SD or LE rats. Thus, the organotropic, but not the strain, selectivity of DMBA-induced carcinogenicity appears to be attributed in part to metabolic activation.
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|